Type of Spiritual Experience
The number of hallucinations comes from the ehealthme web site
A description of the experience
On Dec, 08, 2016 43,006 people reported to have side effects when taking Carboplatin. Among them, 85 people (0.2%) have Hallucination
trade names Paraplatin and Paraplatin-AQ) is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers). It was introduced in the late 1980s.
Carboplatin gained Food and Drug Administration (FDA) approval, under the brand name Paraplatin, in March 1989. Starting in October 2004, generic versions of the drug became available.
“Two theories exist to explain the molecular mechanism of action of carboplatin with DNA:
- Aquation, or the like-cisplatin hypothesis.
- Activation, or the unlike-cisplatin hypothesis.
The former is more accepted owing to the similarity of the leaving groups with its predecessor cisplatin, while the latter hypothesis envisages a biological activation mechanism to release the active Pt2+ species.”
GemCarbo chemotherapy (consisting of gemcitabine, also known as Gemzar, and carboplatin) is used to treat several different types of cancer, but is most commonly used to treat lung cancer GemCarbo chemotherapy is usually conducted as a day patient treatment, involving a blood test the day before.
Immune system damage - 'The main drawback of carboplatin is its myelosuppressive effect. This causes the blood cell and platelet output of bone marrow in the body to decrease quite dramatically, sometimes as low as 10% of its usual production levels. The nadir of this myelosuppression usually occurs 21–28 days after the first treatment. This decrease in white blood cells (neutropenia) can cause complications [sic]. The most notable complication of neutropenia is increased probability of infection by opportunistic organisms, which necessitates readmission to hospital and treatment with antibiotics'. Myelosuppression, is the decrease in cells responsible for providing immunity, carrying oxygen, and those responsible for normal blood clotting.